Craig-Hallum Maintains Schrodinger(SDGR.US) With Buy Rating
Schrodinger Presents SGR-3515 Preclinical Data at ENA 2024
BMO Capital Maintains Schrodinger(SDGR.US) With Buy Rating, Cuts Target Price to $25
Schrodinger Price Target Lowered to $25 From $30 at BMO Capital
Schrödinger to Present New Preclinical SGR-3515 and PRMT5-MTA Data at 2024 EORTC-NCI-AACR Symposium
Is Schrödinger (NASDAQ:SDGR) In A Good Position To Deliver On Growth Plans?
Goldman Sachs Maintains Schrodinger(SDGR.US) With Hold Rating, Raises Target Price to $27
TD Cowen Sticks to Its Buy Rating for Schrodinger (SDGR)
Schrödinger, Inc. (SDGR): Among The Best Medical AI Companies
Schrodinger Is Maintained at Equal-Weight by Morgan Stanley
Schrodinger Analyst Ratings
Morgan Stanley Maintains Schrodinger(SDGR.US) With Hold Rating, Cuts Target Price to $30
Express News | Schrodinger Inc : Morgan Stanley Cuts Target Price to $30 From $43
Analysts Conflicted on These Healthcare Names: Medtronic (MDT) and Schrodinger (SDGR)
Schrödinger Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Schrdinger to Present at Morgan Stanley Global Healthcare Conference
Nvidia-backed Recursion to Acquire Exscientia in All-stock Deal
Investors Still Waiting For A Pull Back In Schrödinger, Inc. (NASDAQ:SDGR)
Craig-Hallum Maintains Schrodinger(SDGR.US) With Buy Rating
BofA Securities Maintains Schrodinger(SDGR.US) With Hold Rating